← Back to headlines
Halozyme Therapeutics Announces Collaboration with GSK
Halozyme Therapeutics (HALO) has announced a new global collaboration and license agreement with GSK.
12 May, 21:28 — 12 May, 21:28
Sources
Showing 1 of 1 sources
Halozyme Therapeutics (HALO) has announced a new global collaboration and license agreement with GSK.
